ANEBULO PHARMACEUTICALS, INC.
Balance Sheet
| Line Item | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $9.0M | $10.4M | $11.6M | $13.3M | $15.0M | $1.4M | $3.1M | $5.1M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $9.3M | $10.5M | $12.0M | $13.8M | $15.4M | $2.0M | $3.5M | $5.4M |
| Property, Plant & Equipment | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $9.4M | $10.7M | $12.1M | $14.0M | $15.8M | $2.5M | $4.1M | $6.0M |
| Liabilities | ||||||||
| Accounts Payable | $554.9K | $607.5K | $224.2K | $427.6K | $319.5K | $252.1K | $156.4K | $384.9K |
| Total Current Liabilities | — | — | — | — | — | — | — | — |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $1.5M | $963.8K | $487.7K | $546.0K | $878.8K | $569.2K | $260.6K | $1.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-78.0M | $-76.0M | $-73.9M | $-71.7M | $-70.1M | $-67.6M | $-65.4M | $-64.1M |
| Total Stockholders' Equity | $7.9M | $9.7M | $11.7M | $13.5M | $15.0M | $1.9M | $3.8M | $5.0M |